Promising results for stem cell therapy in MS

Preliminary findings suggest that nonmyeloablative haematopoietic stem cell transplantation may arrest, or even reverse, the progress of disease among patients with relapsing-remitting multiple sclerosis . The study, which appears in JAMA , involved 145 patients, but had no control group, and outcomes were rated by clinicians who were aware that the patients had received stem cell therapy.

http://ift.tt/15R66JB